PURPOSE: Since we described for the first time a patient with IgG4 autoantibodies to IFN-γ more than 10 years ago, many patients with IFN-γ IgG4 autoantibodies have been described, mostly in Mongolian/ Asian patients with a particular HLA background and in association with disseminated nontuberculous mycobacterial infections. Very recently, the first Caucasian US patient was reported and we now present the case of a 65-year old Caucasian woman with severe disseminated Mycobacterium avium infection, cerebral toxoplasmosis and salmonella sepsis who was tested positive for IFN-γ deficiency due to unusual anti-IFN-γ IgG1 autoantibodies. METHODS: IFN-γ production after ex vivo ConA stimulation of the patient's whole blood and isolated peripheral blood mononuclear cells was assessed. Anti-human IFN-γ antibodies were measured by Ig/Ig-subclass-specific ELISA. In vitro physiologic relevance and blocking capacity of IFN-γ-stimulation by patient's serum was analysed by flow cytometric assessment of cytokine-induced phosphorylation of pSTAT1(Y701). RESULTS: Severely impaired IFN-γ production in the patient's whole blood but normal production in peripheral blood mononuclear cells in the absence of autologous serum was observed. High titre anti-IFN-γ antibodies of the IgG1 subclass could be demonstrated in the patient's serum by ELISA. Further, the addition of patient's serum to IFN-γ-stimulated immune cells showed inhibition of STAT1 phosphorylation. CONCLUSIONS: IFN-γ autoantibodies of any IgG-isotype should be considered in patients with severe opportunistic infections independent of age at onset and ethnicity.
PURPOSE: Since we described for the first time a patient with IgG4 autoantibodies to IFN-γ more than 10 years ago, many patients with IFN-γ IgG4 autoantibodies have been described, mostly in Mongolian/ Asian patients with a particular HLA background and in association with disseminated nontuberculous mycobacterial infections. Very recently, the first Caucasian US patient was reported and we now present the case of a 65-year old Caucasian woman with severe disseminated Mycobacterium avium infection, cerebral toxoplasmosis and salmonella sepsis who was tested positive for IFN-γ deficiency due to unusual anti-IFN-γ IgG1 autoantibodies. METHODS: IFN-γ production after ex vivo ConA stimulation of the patient's whole blood and isolated peripheral blood mononuclear cells was assessed. Anti-human IFN-γ antibodies were measured by Ig/Ig-subclass-specific ELISA. In vitro physiologic relevance and blocking capacity of IFN-γ-stimulation by patient's serum was analysed by flow cytometric assessment of cytokine-induced phosphorylation of pSTAT1(Y701). RESULTS: Severely impaired IFN-γ production in the patient's whole blood but normal production in peripheral blood mononuclear cells in the absence of autologous serum was observed. High titre anti-IFN-γ antibodies of the IgG1 subclass could be demonstrated in the patient's serum by ELISA. Further, the addition of patient's serum to IFN-γ-stimulated immune cells showed inhibition of STAT1 phosphorylation. CONCLUSIONS: IFN-γ autoantibodies of any IgG-isotype should be considered in patients with severe opportunistic infections independent of age at onset and ethnicity.
Authors: Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland Journal: Blood Date: 2012-03-08 Impact factor: 22.113
Authors: Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland Journal: J Immunol Date: 2005-10-01 Impact factor: 5.422
Authors: Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland Journal: N Engl J Med Date: 2012-08-23 Impact factor: 91.245
Authors: Elise O'Connell; Lindsey B Rosen; Richard W LaRue; Valeria Fabre; Michael T Melia; Paul G Auwaerter; Steven M Holland; Sarah K Browne Journal: J Clin Immunol Date: 2014-08-23 Impact factor: 8.542
Authors: Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland Journal: Clin Infect Dis Date: 2020-06-24 Impact factor: 9.079
Authors: Woei-Kang Liew; Koh-Cheng Thoon; Chia-Yin Chong; Natalie W H Tan; Duo-Tong Cheng; Bianca S W Chan; Michelle S Y Ng; Lena Das; Thaschawee Arkachaisri; Chiung-Hui Huang; Jyn-Ling Kuan; Louis Y A Chai; Mark Jean Aan Koh Journal: J Clin Immunol Date: 2019-06-08 Impact factor: 8.542
Authors: Djuro Karanovic; Ian C Michelow; Anthony R Hayward; Suk See DeRavin; Ottavia M Delmonte; Michael E Grigg; Adam Kerry Dobbs; Julie E Niemela; Jennifer Stoddard; Zaid Alhinai; Natasha Rybak; Nancy Hernandez; Stefania Pittaluga; Sergio D Rosenzweig; Gulbu Uzel; Luigi D Notarangelo Journal: Front Immunol Date: 2019-02-14 Impact factor: 7.561